Technical Analysis for PMD - Psychemedics Corporation

Grade Last Price % Change Price Change
F 2.65 2.27% 0.06
PMD closed up 2.27 percent on Wednesday, April 24, 2024, on 15 percent of normal volume.
Earnings due: May 7
*** please verify all earnings dates ***
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Flat

Date Alert Name Type % Chg
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Narrow Range Bar Range Contraction 0.00%
Inside Day Range Contraction 0.00%
Gapped Up Strength 0.00%
180 Bearish Setup Bearish Swing Setup 2.27%
Outside Day Range Expansion 2.27%
Gapped Up Strength 2.27%
Oversold Stochastic Weakness 2.27%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -0.38%
Narrow Range Bar Range Contraction -0.38%

   Recent Intraday Alerts

Alert Time
Rose Above 10 DMA about 7 hours ago
Up 3% about 7 hours ago
Up 2% about 7 hours ago
Up 1% about 7 hours ago
Possible Inside Day about 7 hours ago

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Psychemedics Corporation Description

Psychemedics Corporation provides testing services for the detection of drugs of abuse through the analysis of hair samples in the United States and internationally. The company's testing methods utilize a patented technology that focuses on liquefying hair and releasing drugs trapped in the hair without destroying the drugs. It provides screening and confirmation by mass spectrometry using industry-accepted practices for cocaine, marijuana, PCP, and amphetamines; and opiates, including heroin, hydrocodone, hydromorphone, oxycodone, and codeine. The Company's tests provide quantitative information that can indicate the approximate amount of drug ingested, as well as historical data, which shows a pattern of individual drug use over a longer period of time. Psychemedics Corporation offers its services to employers for applicant and employee testing; physicians, treatment professionals, law enforcement agencies, school administrators, and parents concerned about their children's drug use; and Fortune 500 companies and small to mid-size corporations. The company was founded in 1985 and is headquartered in Acton, Massachusetts.


Classification

Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Law Enforcement Organic Compounds Chemical Compounds Euphoriants Opioids Amines Morphinans Ketones Mass Spectrometry Amphetamine Heroin Hydrocodone Oxycodone Testing Services Cocaine Hydromorphone

Is PMD a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 5.512
52 Week Low 2.05
Average Volume 9,148
200-Day Moving Average 3.35
50-Day Moving Average 2.92
20-Day Moving Average 2.75
10-Day Moving Average 2.63
Average True Range 0.12
RSI (14) 40.48
ADX 15.8
+DI 20.86
-DI 17.88
Chandelier Exit (Long, 3 ATRs) 2.72
Chandelier Exit (Short, 3 ATRs) 2.87
Upper Bollinger Bands 3.02
Lower Bollinger Band 2.47
Percent B (%b) 0.31
BandWidth 19.93
MACD Line -0.10
MACD Signal Line -0.09
MACD Histogram -0.0062
Fundamentals Value
Market Cap 15.35 Million
Num Shares 5.8 Million
EPS -0.68
Price-to-Earnings (P/E) Ratio -3.89
Price-to-Sales 0.75
Price-to-Book 2.28
PEG Ratio 0.00
Dividend 0.14
Dividend Yield 5.29%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 2.71
Resistance 3 (R3) 2.72 2.71 2.70
Resistance 2 (R2) 2.71 2.69 2.70 2.70
Resistance 1 (R1) 2.68 2.68 2.67 2.67 2.69
Pivot Point 2.66 2.66 2.66 2.66 2.66
Support 1 (S1) 2.63 2.64 2.62 2.62 2.60
Support 2 (S2) 2.62 2.63 2.61 2.59
Support 3 (S3) 2.59 2.62 2.59
Support 4 (S4) 2.58